NICOLE FRENCH: Open Payments
NPI 1962169334 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 17 payments from 8 companies in 2025. Trend: 2023 $350 · 2024 $162 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $186 |
| ABBVIE INC. | 4 | $89 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 1 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Indivior Inc. | 1 | $29 |
Products named: INGREZZA, VRAYLAR, Auvelity, Jornay PM, REXULTI, SPRAVATO, CAPLYTA, SUBLOCADE.
Industry payments across CA — which companies pay providers there.
